Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Infect Dis Clin North Am. 2020 Sep 30;34(4):773–819. doi: 10.1016/j.idc.2020.05.001

Table 5.

Clinical indications for the use of meropenem-vaborbactam

Indication Indicated Bacteria Patient Population Clinical Trials
cUTI, including pyelonephritis E coli, K pneumoniae, and Enterobacter cloacae species complex Adult TANGO I168
NCT02166476

Data from Melinta Therapeutics, Inc. VABOMERE (Meropenemand and Vaborbactam) for Injection, for Intravenous Use. Lincolnshire, IL 60069 USA; 2019.